GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Cash Flow from Others

G.Barekat Pharm (XTEH:BRKT1) Cash Flow from Others : IRR-2,737,297 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Cash Flow from Others?

G.Barekat Pharm's cash flow from others for the six months ended in Mar. 2017 was IRR-2,737,297 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2017 was IRR-2,737,297 Mil.


G.Barekat Pharm Cash Flow from Others Historical Data

The historical data trend for G.Barekat Pharm's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Cash Flow from Others Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Cash Flow from Others
-2,322,665.00 -2,737,297.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Cash Flow from Others -2,322,665.00 -2,737,297.00

G.Barekat Pharm Cash Flow from Others Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2017 was IRR-2,737,297 Mil.

G.Barekat Pharm Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines